SRG1 Antibody

Shipped with Ice Packs
In Stock

Description

SRG1 in Plant Immunity

SRG1 is a zinc finger transcription factor (ZF-TF) in Arabidopsis thaliana that regulates plant immune responses. Key findings include:

  • Function: SRG1 acts as a transcriptional repressor by binding to AG/CT motifs in target gene promoters and recruiting the corepressor TOPLESS via its EAR domain .

  • Regulation: Nitric oxide (NO) mediates S-nitrosylation of SRG1 at Cys87, disrupting zinc coordination and DNA binding. This post-translational modification attenuates immune responses by releasing repression of negative regulators .

  • Experimental Tools: Studies utilized FLAG-tagged SRG1 constructs and anti-FLAG antibodies for detection . No antibody specific to SRG1 itself is described.

SRG1 in Yeast Noncoding RNA

In Saccharomyces cerevisiae, SRG1 is a noncoding RNA (ncRNA) that regulates the SER3 gene via transcriptional interference .

  • Mechanism: SRG1 ncRNA transcription across the SER3 promoter blocks RNA polymerase II access, repressing mRNA production .

  • Protein Interaction: Spt2, a histone chaperone, is required for SRG1-mediated chromatin remodeling .

  • Antibody Relevance: Since SRG1 is not translated into a protein, antibodies targeting it are not applicable in this context .

Antibodies Targeting Analogous Systems

While no SRG1-specific antibody is documented, research on related receptors highlights antibody development strategies:

Anti-SR-B1 Antibody (mAb1671)

  • Target: Scavenger Receptor class B type 1 (SR-B1), a hepatitis C virus (HCV) entry receptor .

  • Function:

    • Blocks HDL lipid transfer and HCV E2 glycoprotein binding .

    • Reduces HCV replication in vitro and shows synergy with HDL .

  • Clinical Potential: Demonstrated efficacy in post-liver transplantation settings .

PropertyAnti-SR-B1 (mAb1671)Notes
Target PathogenHepatitis C Virus (HCV)Blocks viral entry mechanisms
MechanismInhibits SR-B1-HDL interactionPrevents lipid transfer
Therapeutic ApplicationPost-transplant HCV prophylaxisPhase Ib trials completed

Experimental Antibody Techniques in SRG1 Studies

  • Tag-Based Detection: In plant studies, anti-FLAG antibodies were used to detect epitope-tagged SRG1 proteins (e.g., FLAG-SRG1 fusion constructs) .

  • Limitations: No commercial or custom antibodies specific to SRG1’s native sequence are reported in the provided sources.

Key Research Gaps

  • Antibody Development: No studies describe SRG1-specific antibodies for plant or yeast applications.

  • Therapeutic Potential: Anti-SR-B1 antibodies (e.g., mAb1671) demonstrate the viability of targeting receptor-ligand interactions, a strategy that could theoretically extend to SRG1 if it were a cell-surface receptor .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SRG1 antibody; At1g17020 antibody; F20D23.28 antibody; F6I1.30Protein SRG1 antibody; AtSRG1 antibody; Protein SENESCENCE-RELATED GENE 1 antibody
Target Names
SRG1
Uniprot No.

Q&A

What is SRG1 and what role does it play in gene regulation?

SRG1 is a noncoding RNA (ncRNA) involved in transcriptional regulation, specifically in the repression of the adjacent SER3 gene. This regulation occurs through a transcription interference mechanism where SRG1 transcription leads to nucleosome deposition that occludes the SER3 promoter. The SRG1 region overlapping the SER3 promoter becomes occluded by randomly positioned nucleosomes that are deposited behind RNA Polymerase II as it transcribes SRG1 . This mechanism represents an important model for understanding transcription-mediated gene silencing through chromatin remodeling.

How do researchers typically detect and analyze SRG1 expression?

SRG1 expression can be detected and analyzed using several complementary techniques:

  • Northern blot analysis using radiolabeled SRG1 probes amplified by PCR

  • Reverse Transcription quantitative PCR (RT-qPCR) for precise quantification

  • Run-on assays to measure active transcription at the SRG1 locus

  • Chromatin immunoprecipitation (ChIP) to assess RNA Polymerase II occupancy at the SRG1 region

These methods allow researchers to distinguish between SRG1 and SER3 transcripts and to measure both steady-state RNA levels and active transcription rates.

What are the key considerations when designing primers for SRG1 detection via RT-qPCR?

When designing primers for SRG1 detection, researchers should:

  • Target unique regions that distinguish SRG1 from SER3 and other transcripts

  • Design primers that can differentiate between full-length and potentially truncated transcripts

  • Consider the secondary structure of the ncRNA, which might impact primer binding

  • Include appropriate reference genes (such as SCR1, which was used in published research) for normalization

Additionally, researchers should validate primer specificity using controls such as deletion mutants (e.g., spt2Δ strain) where SRG1 expression levels are altered.

How can researchers effectively isolate RNA for SRG1 analysis while preserving transcript integrity?

Based on established protocols, researchers should consider using the hot-phenol method for total RNA isolation when studying SRG1. This approach has been successfully employed in published research on SRG1 . The method involves:

  • Rapid lysis of cells in phenol-containing buffer at elevated temperatures

  • Phase separation to isolate RNA from DNA and proteins

  • Subsequent purification steps to obtain high-quality RNA

  • Quality assessment via spectrophotometry and gel electrophoresis

For downstream applications such as Northern blotting, 20-40 μg of RNA should be separated on a 1% agarose formaldehyde-MOPS gel and transferred to a nylon membrane before hybridization with radiolabeled probes .

What is the relationship between Spt2 and SRG1-mediated repression of SER3?

Spt2 plays a critical role in SRG1-mediated repression of SER3. Research has demonstrated that:

  • Deletion of the SPT2 gene results in dramatic derepression of SER3 (30-40 fold increase in mRNA levels)

  • This derepression occurs despite only a modest reduction (approximately 20%) in SRG1 ncRNA levels

  • Spt2 is required for proper nucleosome deposition behind RNA Polymerase II during SRG1 transcription

  • In spt2Δ strains, reduced RNAP II association is observed at the 5' region of SRG1

These findings indicate that Spt2 functions primarily in chromatin organization during transcription rather than directly regulating SRG1 expression levels.

How can researchers experimentally differentiate between transcriptional and post-transcriptional effects on SRG1 regulation?

To differentiate between transcriptional and post-transcriptional regulation of SRG1, researchers should implement a multi-faceted approach:

  • Transcription rate measurement: Employ nuclear run-on assays using probes covering different regions of the SRG1-SER3 locus, as demonstrated in published research

  • RNA stability assessment: Conduct RNA stability assays after transcription inhibition

  • Chromatin state analysis: Perform ChIP assays to measure RNA Polymerase II occupancy along the SRG1 locus

  • Steady-state RNA quantification: Use Northern blot and RT-qPCR analyses to measure RNA levels

  • Genetic approach: Compare results between wild-type and mutant strains (e.g., spt2Δ)

This comprehensive approach allows researchers to determine whether observed changes result from altered transcription initiation, elongation, or post-transcriptional mechanisms.

What antibody-based approaches are most effective for studying transcriptional machinery at the SRG1 locus?

For studying transcriptional machinery at the SRG1 locus, researchers should consider these antibody-based approaches:

  • ChIP assays: Using antibodies against RNA Polymerase II subunits (e.g., Rpb1) to assess polymerase occupancy at different regions of the SRG1-SER3 locus

  • ChIP-seq: For genome-wide analysis of transcription factor binding and histone modifications associated with SRG1 regulation

  • Co-immunoprecipitation: To identify protein interactions within the transcriptional complex at the SRG1 locus

  • Immunofluorescence: For visualization of spatial distribution of transcription factors involved in SRG1 regulation

These approaches can reveal mechanistic insights into how transcription factors like Spt2 coordinate with RNA Polymerase II to regulate gene expression through the SRG1 ncRNA.

How can researchers apply modern antibody engineering techniques to develop tools for SRG1-related research?

Researchers can leverage modern antibody engineering techniques to develop specialized tools for SRG1-related research:

  • Recombinant antibody screening: Utilize Golden Gate-based dual-expression vector systems to rapidly screen and isolate high-affinity antibodies against transcription factors involved in SRG1 regulation

  • Membrane-bound antibody display: Express antibodies on cell surfaces for functional screening, which can be completed within 7 days using established protocols

  • Bispecific antibodies: Engineer antibodies that simultaneously target two components of transcriptional complexes to study their interactions

  • Antibody fragments: Develop smaller antibody fragments (Fab, scFv) with enhanced nuclear penetration for in vivo studies of transcription

These advanced techniques can significantly accelerate the development of research tools for studying the complex mechanisms of transcriptional regulation involving SRG1.

What are the essential controls needed when studying SRG1-mediated transcriptional regulation?

When studying SRG1-mediated transcriptional regulation, researchers should implement these essential controls:

Control TypePurposeExample from Literature
Genetic controlsEstablish baseline and verify phenotypesWild-type vs. spt2Δ strains
Transcript specificityEnsure signal specificityDistinct SRG1 and SER3 probes
Normalization controlsAccount for technical variationSCR1 reference gene
Spatial controlsAssess regional specificityMultiple probes along SRG1-SER3 locus
Technical controlsValidate assay performanceACT1 control in run-on assays

These controls ensure robust and reproducible results when investigating the complex interplay between SRG1 transcription and SER3 regulation.

How should researchers approach experimental design when investigating protein factors involved in SRG1 regulation?

When investigating protein factors involved in SRG1 regulation, researchers should follow this structured approach:

  • Genetic screening: Identify candidate factors through genetic screens (as was done for Spt2)

  • Functional validation: Create deletion or conditional mutants of candidate genes

  • Phenotypic assessment: Measure effects on both SRG1 transcription and SER3 repression

  • Mechanistic studies: Determine the step of regulation affected (initiation, elongation, termination)

  • Protein-chromatin interaction: Use ChIP to map factor binding across the SRG1-SER3 locus

  • Protein-protein interaction: Identify interaction partners through co-immunoprecipitation or proximity labeling approaches

This comprehensive approach allows for thorough characterization of factors like Spt2 that play crucial roles in SRG1-mediated gene regulation.

How can researchers resolve discrepancies between SRG1 transcript levels and transcriptional activity measurements?

Resolving discrepancies between SRG1 transcript levels and transcriptional activity requires multi-dimensional analysis:

  • Integrate multiple assays: Compare results from Northern blot, RT-qPCR, run-on assays, and ChIP to build a complete picture

  • Regional analysis: Assess transcription at different positions along the SRG1 locus using positioned probes

  • Temporal dynamics: Consider the timing of transcription, nucleosome deposition, and RNA degradation

  • RNA stability assessment: Determine if post-transcriptional mechanisms affect steady-state RNA levels

  • Quantitative modeling: Develop mathematical models that account for transcription rates, RNA processing, and degradation

Published research has demonstrated that deletion of SPT2 resulted in only a 20% reduction in SRG1 ncRNA levels despite significant decreases in transcriptional activity as measured by run-on assays and RNAP II ChIP . This highlights the importance of using complementary methods to fully characterize transcriptional regulatory mechanisms.

What next-generation sequencing approaches are most informative for studying SRG1-mediated regulation?

Several next-generation sequencing approaches can provide valuable insights into SRG1-mediated regulation:

  • RNA-seq: For comprehensive analysis of transcriptional changes across the genome

  • ChIP-seq: To map binding sites of transcription factors and histone modifications

  • NET-seq (Native Elongating Transcript sequencing): To capture nascent RNA and active transcription sites

  • ATAC-seq: To assess chromatin accessibility changes resulting from SRG1 transcription

  • Hi-C or Micro-C: To investigate potential three-dimensional chromatin interactions involving the SRG1-SER3 locus

These approaches, when integrated with traditional biochemical assays, can reveal the complex interplay between transcription, chromatin structure, and gene regulation at the SRG1-SER3 locus.

How can multiplexed antibody detection systems be applied to study transcriptional regulation complexes?

Multiplexed antibody detection systems offer powerful approaches for studying transcriptional regulation:

  • Multiplex immunoassays: Develop Luminex-based assays similar to those used for SARS-CoV-2 antibody detection but adapted for detecting multiple transcription factors simultaneously

  • CyTOF/Mass cytometry: Use metal-tagged antibodies for highly multiplexed detection of nuclear proteins

  • Sequential immunofluorescence: Apply cyclic immunofluorescence to detect multiple components of transcriptional complexes in situ

  • Proximity ligation assays: Detect protein-protein interactions within transcriptional complexes with high specificity

These approaches allow researchers to monitor the dynamic assembly and composition of transcriptional regulatory complexes involved in SRG1-mediated gene regulation.

What are the cutting-edge methods for developing antibodies against difficult transcription-related targets?

For developing antibodies against challenging transcription-related targets, researchers should consider:

  • In vivo expression systems: Utilize membrane-bound antibody expression systems with Golden Gate cloning for rapid antibody screening, as demonstrated in recent research

  • Next-generation sequencing integration: Combine single-cell isolation with DNA barcode technology and NGS for high-throughput antibody discovery

  • Structure-guided design: Use structural information about transcription factors to design antibodies targeting functional domains

  • Synthetic antibody libraries: Screen phage or yeast display libraries of engineered antibody fragments against challenging epitopes

  • Alternative binding scaffolds: Consider non-antibody protein scaffolds optimized for binding to specific protein surfaces

The Golden Gate-based dual-expression vector system described in recent literature allows for the expression of membrane-bound immunoglobulins and rapid enrichment of antigen-specific, high-affinity antibodies by flow cytometry , which could be particularly useful for developing research tools for studying SRG1 regulation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.